Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection

Peer Review reports

Original Submission
9 May 2022	Submitted	Original manuscript
3 Aug 2022	Reviewed	Reviewer Report
11 Aug 2022	Reviewed	Reviewer Report - Ahmet Emin Erbaycu
19 Oct 2022	Author responded	Author comments - Thomas Klikovits
22 Oct 2022	Author responded	Author comments - Thomas Klikovits
Resubmission - Version 2
19 Oct 2022	Submitted	Manuscript version 2
4 Nov 2022	Reviewed	Reviewer Report
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
9 Nov 2022	Editorially accepted
19 Nov 2022	Article published	10.1186/s12885-022-10298-9

Back to article page